Impaired tactile acuity in people with chronic pain conditions has been suggested to reflect altered cortical representation of the painful body part and treatments that aim to improve tactile acuity in these conditions have shown clinical benefit. Whether abnormalities in tactile acuity are a consistent feature of chronic pain remains largely unknown. The aim of this review was to systematically evaluate the literature and use meta-analysis to establish whether tactile acuity is altered in people with chronic non-neuropathic pain. We systematically searched the literature for studies that investigated tactile acuity in people with chronic non-neuropathic pain and compared it to an appropriate control group. Sixteen studies, reporting data from five chronic pain conditions were included. Data were available for 18 chronic pain populations (n = 484) and 15 control populations (n = 378). Our results suggest that tactile acuity is diminished in arthritis, complex regional pain syndrome and chronic low back pain, but not in burning mouth syndrome. The strength of the available evidence is weakened by somewhat inconsistent results and the high risk of bias observed in all of the included studies.
Introduction
Tactile acuity refers to the precision with which we can sense touch 18 , and this precision is thought to be impaired in some chronic pain conditions 48 . However, these impairments cannot be explained by deficits in tactile detection 45, 68 or transmission 63 and thus are thought to reflect cortical changes including a functional reorganisation of the response profile of neurons in the primary sensory cortex (S1) 17, 39, 64 . Discriminative ability is dependent on the integrity of S1 12 , hence in some chronically painful conditions, cortical reorganisation appears to manifest as reduced tactile acuity at the affected bodily region.
Whether tactile acuity deficits and cortical reorganisation characterise all pain conditions remains largely unknown. This is important because treatments that aim to improve tactile acuity have shown clinical benefit in a number of chronic pain conditions 16, 46, 47, 69, 70 . There seems to be a growing view that tactile acuity deficit is a generic finding in chronic pain 48, 65 , irrespective of pathology or condition. If so, tactile acuity training might have a greater generic applicability than has currently been demonstrated. Despite this growing interest, there has been no attempt to systematically establish the evidence of tactile acuity deficits in chronic pain.
We aimed to systematically evaluate the literature and use meta-analysis to establish whether tactile acuity is consistently altered in people with chronic pain. We focused our review on non-neuropathic pain conditions, as peripheral lesions of the somatosensory pathways may disrupt the transmission of tactile stimuli from the periphery and thus account for diminished acuity evident in neuropathic pain conditions 26, 57, 62 . Primarily, we sought to determine whether tactile acuity is altered at the site of pain and/or at regions remote from the site of pain. Our secondary aims were to determine whether the deficits in tactile acuity relate to pain intensity or to the duration of pain. 
Methods
A systematic review of the peer-reviewed scientific literature was undertaken to locate studies that reported tactile acuity data for people with chronic pain. A review protocol was designed a priori in accord with the Cochrane Handbook for Systematic Reviews 24 and Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 44 guidelines.
Data sources
Candidate studies were identified in June 2013 via a computer search of online bibliographic databases (AMED, CINAHL, Cochrane Library, Embase, Medline, PsycINFO, Scopus and Web of Science). Each database was searched separately from its inception and the search string proximity operators and expanders were appropriately customised for each database (see supplemental information for the Medline search string). No restrictions were placed on the language of the articles or the publication date. All duplicates were removed.
Study selection
All titles and abstracts (where available) were initially screened independently by two reviewers (MC and CB) to identify eligible articles. The full-text articles of the potentially relevant studies were retrieved and reviewed independently by the same pair of reviewers.
Study eligibility was compared at each stage and any discrepancies were resolved by discussion between the two reviewers, or if agreement could not be reached, a third reviewer (NO).
Studies were included if they potentially reported tactile acuity data on a population of chronic pain patients. Studies were excluded if: tactile acuity data were not reported for a definable chronic pain group (pain persisting for 3 months or longer 42 ); control data were not M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 5 reported (from a separate control group or the unaffected side); the sample included people diagnosed with a central neurological disorder (e.g. stroke, multiple sclerosis), demonstrable nerve injuries (includes nerve compression injuries diagnosed electrophysiologically) or repairs; or the presented data were duplicated from an existing excluded study. The reference lists of all relevant studies were examined and cross-referenced to identify additional studies.
Outcome measures
Measures of tactile acuity were the primary outcomes of interest in this review. Comparable measures included tests of two-point discrimination, tactile spatial localisation and grating orientation tasks. Comparisons of graphesthesia were not considered because they are task performance based rather than distance based. Secondary outcome measures were pain duration and pain intensity (e.g. visual analogue scale (VAS), numerical rating scale (NRS),
McGill Pain Questionnaire (MPQ)).
Risk of Bias assessment and data extraction
Two reviewers (MC and CB) independently assessed the included studies for risk of bias.
The form used was based on the STROBE statement 66 and relevant items for case-control study designs from the Cochrane collaboration's tool for assessing bias (see supplemental information) 4, 24 .
Data extraction was completed independently by the two reviewers (MC and CB) using a customised data extraction sheet. The data extraction sheet was piloted on several studies prior to the commencement of the search. The following descriptive data were extracted from each included study: age, gender, sample size, chronic condition, region of pain, region assessed, pain intensity, pain duration. Extracted outcome measures were: mean (SD) tactile acuity, assessment protocol, assessment tool, bodily region of pain (for the patient group), bodily region assessed and any association data comparing tactile acuity and pain intensity M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 6 and/or pain duration. Reviewer differences were resolved through discussion or if an agreement could not be reached, a third reviewer (NO) would arbitrate.
The authors of the included studies were contacted to clarify the details of their study and to request raw data, which included measures of pain intensity and/or pain duration. Raw data were entered into SPSS Statistics (v21.0.0.0, IBM Corporation, New York). Tactile acuity data were entered in millimetres and pain duration data were entered in months.
Data analysis and synthesis

Comparing tactile acuity between people with chronic pain and controls
Studies that compared the tactile acuity of people with chronic pain to the tactile acuity of controls were first split into two groups: studies that compared tactile acuity assessed at the painful region and studies that compared the tactile acuity at a site remote from the painful region. The study data were then sub-grouped by chronic pain condition (determined a priori) for comparison. Quantitative analysis was conducted using Review manager (Revman v5.2.5, The Nordic Cochrane Centre, Copenhagen) software. Studies were excluded from the quantitative analysis if they did not report sufficient data and the necessary data could not be obtained from the authors. When possible, mean and standard deviation values were calculated from raw data. To simplify the comparison, in studies which included raw data for bilateral pain conditions, the mean (SD) of the left and right sides was compared with the control data. In instances where the same study reported several results on the same sample, the weighting was adjusted by dividing the sample size by the number of regions presented for that subgroup. Studies were pooled by the inverse variance method with a random effects model using the standardised mean difference (SMD) as the measure of effect size (Hedge's g). SMD was used instead of the weighted mean difference to better account for the predicted variation in acuity levels between studies of different body regions. Effect estimates were
interpreted as small (0.2), moderate (0.5) or large (>0.80) 9 . To further aid the interpretation of the pooled effect sizes, the SMD of a subgroup in which all assessments were conducted at skin regions of comparable receptive field densities were back-transformed to a mean difference in millimetres using the averaged (mean) standard deviation from the control data.
The mean difference was then expressed as a percentage of the control group tactile acuity.
As this calculation uses the averaged standard deviation, taken from studies that used differing protocols and assessment tools, the results should be considered an estimate.
All forest plots were visually inspected and a sensitivity analysis was conducted if the effect estimate of a dataset, within a subgroup, appeared substantially different from the other studies and thus may have influenced the pooled effect estimate.
Comparing tactile acuity between the affected and unaffected sides of people with unilateral chronic pain conditions
The tactile acuity of the affected and unaffected sides of people with unilateral chronic pain was compared. The study data were grouped by chronic pain condition and the analysis was conducted as for the aforementioned comparisons.
Relationship between tactile acuity and pain intensity and duration
Correlational data were extracted and presented. For studies where raw data were available, correlation coefficients were calculated. Furthermore, a Spearman's correlation coefficient (r s ) was calculated to estimate the overall relationship between tactile acuity and the intensity and duration of pain. Tactile acuity data were transformed into z-scores and pooled. Average Figure 1 outlines the results of the systematic review process (PRISMA flow chart). The initial search identified 2621 studies. Of these, 2531 were excluded in the initial screening of titles and abstracts. A further 74 were excluded following the review of the full text. The most common reason for exclusion was a lack of control data (unaffected side or independent healthy sample). Other common reasons for exclusion included peripheral nerve injuries, central nervous disorders or secondary analyses. No additional studies were identified from searching the reference lists of the eligible studies. In total, 16 studies -reporting data for 484 people with chronic pain and 378 control individuals -were included in the analysis. ***INSERT FIGURE 1 ABOUT HERE*** All the authors of the 16 included studies were contacted for their raw data and to clarify some details of their studies that were not clear from the study report. The authors of five studies 3, 20, 58-60 did not respond. The raw data for three studies was unobtainable because it had been destroyed 51 or the authors reported that it was currently inaccessible 32, 50 . Raw data were obtained for the remaining eight studies 2, 34, 37, 45, 54, 55, 61, 68 . Table 1 summarises the study characteristics of the 16 included studies. Fifteen studies compared people with chronic pain to control individuals, including five studies 32, 37, 50, 54, 61 which also compared tactile acuity at the site of pain to that of the contralateral unaffected region. One study 58 All of the included studies used the two-point discrimination threshold (TPDT) as a measure of tactile acuity. Eleven studies 2, 20, 32, 34, 45, 51, [58] [59] [60] [61] 68 used commercially available, clinically applicable tools while five studies 3, 37, 50, 54, 55 used custom-made assessment tools. Two studies 3, 58 failed to clarify (or adequately reference) their protocols sufficiently for replication; attempts to contact these authors were unsuccessful. Whether tactile acuity was assessed directly within the painful region was unclear.
Results
Study Characteristics
Six studies used recognised diagnostic criteria. Maihöfner & DeCol , Pleger et al. 54 
Risk of bias
Outcomes
Is tactile acuity altered at the painful region in people with chronic pain?
Eleven studies 2, 7, 20, 32, 34, 37, 45, 50, 54, 55, 68 assessed tactile acuity at the painful region and compared it with the same region in controls. The forest plot shown in Figure 2 compares the tactile acuity of people with chronic pain (n = 296) to that of controls (n = 341). The pooled results of all comparisons suggest TPDTs are larger at the site of pain in people with chronic pain than they are in controls. A large, significant effect estimate of 1.02 (95% confidence interval (CI): .59 to 1.46, p < .0001) in favour of worse tactile acuity in people with chronic pain was noted. However, heterogeneity was high (I 2 = 81.8%, p = .0009) and there were apparent differences between diagnostic subgroups.
Arthritic pain
Two studies 2, 61 compared the tactile acuity of people with chronic arthritic pain to that of controls. Despite differences in protocols and assessment tools used, heterogeneity within this subgroup was not statistically significant (p = .13). The pooled results of five comparisons suggest TPDTs are larger at the site of pain than they are in controls; a large significant effect estimate of 1.48 (95% CI: .77 to 2.19, n = 24). However, the results appear inconsistent with
a difference in acuity observed at the knee in people with knee osteoarthritis but no differences in acuity at the fingertip in people with hand osteo-and rheumatoid arthritis.
Burning mouth syndrome
One study 20 compared the tactile acuity of people with burning mouth syndrome to that of controls. The pooled results of 8 oral regions assessed suggest TPDTs are not altered in people with burning mouth syndrome (effect estimate .02, 95% CI: -.37 to .41 with no heterogeneity). This equates to a difference of .1 mm (95%CI: -1.4 mm to 1.6 mm), or a percentage difference of 0% (95% CI: -18% to 19%) between the people with BMS and controls.
Complex regional pain syndrome
Five studies 32, 37, 50, 54, 55 compared the tactile acuity of people with CRPS to that of controls.
The pooled results of five comparisons suggest TPDTs are larger at the site of pain in people with CRPS than they are in controls; a large, significant effect estimate of 2.34 (95% CI: .86 to 3.83, p = .002) in favour of worse tactile acuity in people with CRPS. This equates to a difference of 1.1 mm (95%CI: .4 mm to 1.8 mm), or a percentage difference of 47% (95% CI: 17% to 76%) between the people with CRPS and controls. However, substantial heterogeneity was observed for this comparison (I 2 = 94%, p < .00001) even though all of the included studies demonstrated statistically significant differences in TPDTs. The results of Peltz et al. 50 had much lower variance than the other studies, which may have contributed to their remarkably large effect size (6.48 (95% CI: 5.18 to 7.79) (see Appendix for further discussion of the Peltz et al. 50 50 study removed (I 2 = 69%, p = .02). This equates to a difference of .8 mm (95%CI: .4 mm to 1.1 mm), or a percentage difference of 31% (95% CI: 16% to 47%) between the people with CRPS and controls.
Low back pain
Four studies 34, 45, 61, 68 compared the tactile acuity of people with CLBP to that of controls.
The pooled results of five comparisons suggest TPDTs are larger in people with CLBP; a large, significant effect estimate of 1.14 (95% CI: .54 to 1.74, p = .0002) in favour of worse tactile acuity in people with CLBP. This equates to a difference of 11.7 mm (95%CI: 5.5 mm to 17.8 mm), or a percentage difference of 26% (95% CI: 12% to 39%) between the people with CLBP and controls. Substantial heterogeneity for this comparison was observed (I 2 = 69%, p = .01).
Is tactile acuity altered in regions remote from the region of pain, in people with chronic pain?
Eight studies 3, 32, 37, 50, 51, 54, 59, 61 assessed tactile acuity at a site remote from the region of pain. The remote locations where tactile acuity was assessed are described in the forest plot in 
Arthritic pain
Two studies 3, 61 compared the tactile acuity of people with chronic arthritic pain to that of controls. The pooled results of two comparisons suggest TPDTs are larger at regions remote from the site of pain in people with chronic arthritic pain; a large, significant effect estimate of 1.40 (95% CI: .99 to 1.82, p < .00001) in favour of worse tactile acuity in people with arthritis. Despite differing protocols (i.e. Batterman 3 assessed the TPDT with custom built an air jet apparatus) and differing clinical presentations (i.e. Batterman 3 did not report which joints were affected), heterogeneity was not detected (I 2 = 0%, p = .94).
Complex regional pain syndrome
Four studies 32, 37, 50, 54 compared the tactile acuity of people with CRPS to that of controls.
The pooled results of four comparisons suggest TPDTs are larger at regions remote from the site of pain in people with CRPS; a small, significant effect estimate of .33 (95% CI: .01 to .64, p = .04) in favour of worse tactile acuity in people with CRPS. This equates to a difference of .13 mm (95%CI: 0 mm to .24 mm), or a percentage difference of 5% (95% CI: 0% to 10%) between the people with CRPS and controls. Heterogeneity was not detected (I 2 = 0%, p = 0.56) but a sensitivity analysis was conducted with the Peltz et al. 50 study excluded (see Supplemental information, Fig. 8 ). The pooled results of the remaining three studies suggest TPDTs are not altered at regions remote from the site of pain in people with CRPS (95% CI: -.17 to .61, p = .28), which suggests that the significant pooled effect was probably carried by the Peltz et al. 50 data.
Low back pain
One study 51 compared the tactile acuity of people with CLBP to that of controls. The results suggest TPDTs are not altered at regions remote from the site of pain in people with CLBP (95% CI: -.26 to .88).
Nonspecific chronic pain
One study 59 compared TPDTs at the forearm in people with chronic pain in various bodily regions to the forearm TPDTs of controls. The results suggested TPDTs at the forearm are larger in people with chronic pain; a moderate, significant effect estimate of .77 (95% CI: .09 to 1.45, p = .03) in favour of worse tactile acuity in people with chronic pain. This equates to a difference of 5.7 mm (95%CI: .7 mm to 10.7 mm), or a percentage difference of 19% (95% CI: 2% to 35%) between the people with nonspecific chronic pain and controls. However, these data included people with arm and generalised pain.
An additional study not included in the overall analysis 60 , compared TPDTs at the forearm in patients with unspecified chronic pain (i.e. patient condition was not reported) to the forearm TPDTs of controls. They noted a significant difference (t(12) = 2.78, p < .02) but insufficient data were reported for its inclusion in the meta-analysis.
Comparing tactile acuity of the affected and unaffected sides of people with chronic pain
Six studies 37, 50, 52, 54, 58, 61 
Arthritic pain
One study 61 compared the tactile acuity of the affected and unaffected knees of people with chronic knee OA. The results suggest the TPDT of the affected side is not altered in comparison with the unaffected side (95% CI: -.26 to 1.14).
Complex regional pain syndrome
Four studies 32, 37, 50, 54 was noted. This equates to a difference of 1.2 mm (95%CI: .2 mm to 2.2 mm), or a percentage difference of 47% (95% CI: 10% to 87%) between the affected and unaffected sides. As noted above, substantial heterogeneity was observed for this comparison (I 2 = 95%, p < .00001) likely due to the results of the Peltz et al. 50 study which had an effect size 3.5 times the pooled estimate. A sensitivity analysis was conducted with the Peltz et al. 50 data excluded (see supplemental information, Figure 9 ). The overall pooled results of the remaining three comparisons suggests TPDTs are larger at the site of pain in comparison with the contralateral unaffected region (effect estimate 1.22 95%; CI: .43 to 2.02). This equates to a difference of .8 mm (95%CI: .3 mm to 1.2 mm), or a percentage difference of 29% (95% CI: 10% to 46%) between the affected and unaffected sides.
Low back pain
One study 58 of pain was noted. This equates to a difference of 1.4 mm (95%CI: .7 mm to 2.0 mm), or a percentage difference of 58% (95% CI: 29% to 86%) between affected and unaffected sides.
Relationship between tactile acuity and pain intensity
Seven studies 32, 37, 50, 54, 55, 61, 68 reported the relationship between tactile acuity and pain intensity and the relationship could be calculated from the raw data of one further study 45 . Table 3 shows the correlation data for the eight studies and Figure 5 compares tactile acuity and current pain intensity for the six studies that provided raw tactile acuity and pain intensity data. 54 (n = 17) noted a statistically significant relationship between tactile acuity and average pain intensity (p = .001) but not current pain intensity (p = .157), both using the NRS. Analysis of the pooled data showed no significant association between tactile acuity and pain intensity (p = .218).
Relationship between tactile acuity and pain duration
Two studies 61, 67 reported the relationship between tactile acuity and pain duration. Raw data were available for both of these studies and for a further three studies 2, 45, 54 that did not report the relationship. Figure 6 plots the data for people with OA (hands and knee), RA (hands), CRPS and CLBP.
M A N U S C R I P T
A C C E P T E D ACCEPTED MANUSCRIPT 17 Stanton et al. 61 noted that pain duration was not related to TPDTs in people with knee OA (n = 20, p = .60) or CLBP (n = 17, p = .61). Wand et al. 68 (n = 19) also found no significant correlation between TPD thresholds and the duration of CLBP (partial r = -.169, p = .516).
The raw data from the Ayhan et al. 2 (n = 43 OA, 28 RA), Moseley 45 (n = 6) and Pleger et al. 54 (n = 17) studies were analysed and no further significant relationships were identified between TPDTs and pain duration (p > .90). Analysis of the pooled data showed no significant association between tactile acuity and pain duration (p = .242).
Discussion
We aimed to systematically evaluate the literature and use meta-analytical methods to establish whether tactile acuity is altered in people with non-neuropathic chronic pain. The overall pooled results suggest the tactile acuity of people with non-neuropathic chronic pain is worse at both the site of pain and at regions remote from the site of pain in comparison to control individuals. However, the reduction in acuity observed at remote sites is only clearly present in the arthritis data. While tactile acuity deficits were not evident in all of the included chronic pain conditions, none of the included studies associated chronic pain with an enhancement of tactile acuity.
In CRPS, there is consistent evidence showing tactile acuity, assessed at the fingertip, is worse at the affected hand than both the unaffected hand and the hands of pain-free controls suggesting that the impairment is restricted to the area of pain. Given the association between tactile acuity and S1 representation 12 , these findings are in keeping with evidence of an altered cortical representation of the affected hand, as compared to the unaffected hand, in people with CRPS 28, 36 (see Di Pietro et al. 11 for a review).
We found consistent evidence to suggest tactile acuity deficits in people with CLBP are restricted to the painful back region. As with the CRPS data, these findings appear to be M A N U S C R I P T
A C C E P T E D ACCEPTED MANUSCRIPT
18 consistent with cortical reorganisation at the back 14 , however we are not aware of any data to suggest S1 representation is normal in unaffected regions.
In arthritic conditions, we found evidence of altered acuity at both the site of pain and at remote regions, suggesting acuity is generally altered across the body. However, Stanton et al. 61 categorized the contralateral knee as unaffected if it was pain-free at the time of testing.
That many of the participants reported a history of pain in the unaffected knee 61 and that current pain intensity does not correlate with tactile acuity may account for the deficits observed in the remote region. Furthermore, Batterman 3 failed to report which joints were affected and it is possible that joints near the assessment site on the forearm (i.e. the wrist) were affected and inflated the size of the difference at the remote site. While cortical changes are thought to contribute to the pain associated with OA and RA 31, 49 , we are not aware of any evidence of cortical reorganisation in these conditions. That deficits in acuity may not be isolated to the region of pain suggests that S1 reorganisation alone may not account for the impairment and other cortical or subcortical areas might be involved. Nonetheless, arthritic conditions are associated with altered touch perception 23 and pain thresholds 23, 25, 40 , indicative of peripheral and central sensitisation 41, 56 , and hyperalgesia, a marker of central sensitization, directly relates to the extent of cortical reorganisation in other chronic pain conditions 36 . Further studies, using appropriate protocols and remote sites, are needed to further interrogate this phenomenon in arthritic conditions. Only one study 20 investigated tactile acuity in burning mouth syndrome and found no differences in comparison to healthy controls. This poorly understood condition is thought to be mediated centrally 19 but to date there is no evidence of cortical reorganisation in the burning mouth syndrome literature. That no differences between touch perception or tactile acuity were observed suggests burning mouth syndrome is not associated with peripheral neural abnormalities or disruption of the sensory neuraxis.
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Tactile acuity does not appear to worsen as pain worsens or persists in the period 3 months after the initial injury. We found little evidence of a relationship between tactile acuity and pain intensity. A significant relationship between tactile acuity and pain intensity was only noted in three studies, each in CRPS samples. The identical findings of Maihofner and DeCol 37 and Peltz et al. 50 suggested a significant relationship between acuity and current pain intensity. Conversely, Pleger et al. 54 reported a significant relationship between acuity and average pain intensity but found no relationship between acuity and current pain intensity.
These conflicting results, and that no further relationships were identified in our analysis of five additional datasets, suggest tactile acuity deficits may be independent of the perceived intensity of the pain. This is surprising given the relationship between tactile acuity and S1 representation 12 and between the extent of S1 reorganisation and average pain intensity in both CRPS 36, 38, 53 and PLP 13, 15, 21 . Although S1 hyperactivity increases with chronicity 14 , we found no evidence of a relationship between pain duration and tactile acuity. These findings suggest tactile acuity does not worsen as pain persists and infer S1 hyperactivity is not directly related to deficits in tactile acuity. However the available data regarding these relationships are limited. It is, nonetheless, plausible that the changes in tactile acuity occur in the acute and subacute phases and we were unable to detect a relationship because we only included studies of participants with pain that has persisted for greater than 3 months.
While some chronic non-neuropathic pain conditions appear to be associated with deficits in tactile acuity, the point at which a deficit becomes clinically meaningful remains unknown.
However, previous studies have addressed the issue of assessment and provided guidelines as to the size of the difference needed to be distinguishable from measurement error 71 .
All of the included studies used the TPDT as a measure of tactile acuity and the differences between the assessment protocols and tools likely contributed to the observed heterogeneity.
The TPDT is the most common measure of tactile acuity 26 as it is easy to assess and is M A N U S C R I P T
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20 appropriate for use in regions of high and low acuity 8 . However, it has been criticised for the unexplained variability observed within subjects 71 , between subjects and between studies 27 and some researchers argue it should not be used as a scientific measure of acuity 10 . It is vulnerable to bias insofar as most protocols require the assessor to make a subjective judgment as to when the threshold has been determined. Future studies should consider other measures of tactile acuity such as grating orientation tasks 18 and consider the influence of assessor bias and test-retest reliability. Nonetheless, despite wide variability and small sample sizes, most of the studies included in this review reported statistically significant findings.
All of the included studies were at risk of bias, primarily due to non-consecutive recruitment, the lack of exclusion based on recognised diagnosis criteria, and the use of non-blinded assessors. Furthermore, while it is well documented that tactile performance declines with age 30, 72 , few studies reported age-matching their control group. It is thus plausible that the effect estimates reported in this review may overestimate the true disparity in acuity between people with chronic pain and controls. That all of the included studies which hypothesised that tactile acuity would be altered because of cortical reorganisation were statistically significant 32, 34, 37, 45, 50, 54, 55, 61, 68 , despite the small samples and the wide variability associated with tests of acuity, suggests a publication bias may also have influenced our results 33 .
Several limitations may have influenced our findings. We only excluded studies that provided explicit evidence of overt peripheral neuropathy. Impaired touch perception can be indicative of nerve injury 35 and will likely impair tactile acuity, yet only four studies 2, 20, 45, 68 provided evidence of normal sensory detection. Additionally, none of the CRPS studies included nerve conduction velocity or electromyographic assessments to exclude nerve lesions which suggests CRPS-II cannot be ruled out definitively 5 . We also did not restrict the age range of the participants and several of the studies included older adults. Tactile acuity progressively M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 21 declines across the lifespan 6, 29 and age-matching was not consistently achieved. It is plausible that some of the observed deficits in acuity were due to peripheral abnormalities or due to age-related changes. Two of the studies used controls that were not pain-free 45, 61 and one study did not include a control group 58 . It is unknown whether these data inflated the differences between the groups or reduced them. Finally, the tactile acuity data reported by Peltz et al. 50 differed substantially from the other CRPS studies. The effect sizes from that study were up to five times larger than the pooled estimates, and well beyond 0.8, which is the generally accepted size of a 'large' effect 9 . The authors assured us that the anomalies in that data (see Appendix) were coincidental, but the possibility of reporting errors cannot be excluded. We undertook sensitivity analyses with the Peltz et al. 50 data removed to ensure that these outlying results did not carry the main finding. While, the pooled effect sizes and heterogeneity were reduced, the findings remained consistent, with the exception of the finding that tactile acuity was altered at sites remote from the painful site. The sensitivity analysis suggested TPDTs are not altered at remote sites, and we thus contend that the most prudent position is to conclude that a difference between acuity at sites remote from the site of pain probably does not exist.
In summary, the current evidence suggests that tactile acuity is altered in several chronic pain conditions. However, the strength of the available evidence is weakened by the inconsistent results and the high risk of bias observed in the included studies. Nonetheless, the current findings suggest that tactile acuity deficits may be characteristic of chronic pain in general.
Tactile acuity training may be of benefit to the wider range of chronic pain disorders and clinical trials of this possibility appear warranted. Note: * = current pain intensity unless specified; ? = not reported; ǂ = calculated from raw data (not reported in manuscript). 
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Risk of Bias Assessment
The following assessment was modified and piloted prior to commencement of the review.
Each assessment category was marked as follows:
• Yes; clearly described or appropriately referenced within paper. 
Statistical Methods and Study Size (Reporting bias)
YES NO ? Was the method of determining study size described and appropriate (a priori sample size calculations -power) OR was the sample size for each group in excess of 30 persons?
Were the confounding variables controlled for? (e.g. by study design, such as matched controls, or statistical analysis) Comments:
Missing Data (Reporting bias)
YES NO ? Are all outcomes and groups actually reported (e.g. compare aims, methods, and results to make sure) (If yes, please fill in the next box)
Were methods for dealing with missing data described and appropriate? Describe the methods used and impute the data below Comments:
Performance bias YES NO ?
Were outcome assessors blinded to group status?
Were reliable measures used for assessment of acuity? (i.e. were reliability indices reported or appropriately and clearly referenced) Was the protocol for assessing tactile acuity clearly reported or appropriately referenced? (i.e. could the protocol be replicated from the details provided?) 
Comments
